Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Management of common vismodegib (VISMO)-related adverse events in patients with locally advanced basal cell carcinoma (laBCC): RegiSONIC Disease Registry Study Lacouture, M. E., Guillen, J., Kudchadkar, R., Rogers, G., Olencki, T., Tang, J., Yoo, S., Dawson, K., Mun, Y., Sekulic, A. MOSBY-ELSEVIER. 2016: AB200
View details for Web of Science ID 000412760201665